Summary: To investigate the regulation of drug absorption from the small intestine by the enteric nervous system (ENS), the vascular-luminal perfusion study and the in-vitro transport study were performed by employing phenol red as a poorly absorbable model compound. The eŠect of ENS on the intestinal absorption of phenol red was examined by adding epinephrine, an adrenergic agonist, or bethanechol, a cholinergic agonist into the vascular perfusate in the vascular-luminal perfused rat smallintestine preparation. The viability of the perfused intestine was checked by the recovery of the vascular perfusate, net water ‰ux and absorbability of antipyrine, a well absorbable drug, and it was conˆrmed that the function of the perfused small-intestine preparation was maintained for at least 1 hr. The eŠect of epinephrine or bethanechol on the function of the small intestine was recognized as the increase in net water absorption, or the promotion of the water secretion, respectively. These phenomena are ones that are typically observed when adrenergic or cholinergic neuron is stimulated. Then, we investigated the small-intestinal absorption of phenol red in the vascular-luminal perfused preparation. Absorption clearance (CLabs) of phenol red was gradually increasing during the perfusion for 1 hr, but the 20-min vascular perfusion with the perfusate containing epinephrine made CLabs of phenol red constant and signiˆcantly lower than those for control study. Furthermore, after the perfusate was changed with the one without any agonist, again, CLabs of phenol red started to increase. These results clearly indicate that the stimulation of adrenergic neuron by epinephrine leads to the decrease in the small-intestinal absorption of phenol red. On the other hand, the vascular perfusion of bethanechol resulted in the increase in CLabs of phenol red comparing to the control study. Removing bethanechol from the vascular perfusate decreased CLabs of phenol red, again. The in-vitro transport study using the isolated jejunum sheet also showed that epinephrine in the serosal solution signiˆcantly decreased the transport of phenol red, which can be ascribed to the paracellular pathway tightened by the action of epinephrine because of the increase in transmucosal electrical resistance (TER). On the other hand, although the eŠect of bethanechol on both the transport of phenol red and TER was not statistically signiˆcant, the transport of phenol red tended to increase and the values of TER are smaller than those of control study.
Introduction
The small intestine has an intrinsic nervous system, the enteric nervous system (ENS), which is recognized as an independent integrative system with structural and functional properties similar to those of the central nervous system. 1) ENS consists of two ganglionated plexuses, the myenteric plexus and the submucosal plexus. Myenteric ganglia are distributed between the longitudinal and circular muscle layers and myenteric neurons mainly regulate contractile activity such as segmentation, mixing movements and peristalsis. [1] [2] [3] On the other hand, submucosal ganglia embedded in the submucosa and submucosal neurons are mainly involved with epithelial function and blood ‰ow. [4] [5] Interconnectingˆbers between the myenteric and sub-mucosal plexuses function to coordinate motility and transport functions. 5) From the aspect of type of neurons, ENS is composed of cholinergic, adrenergic and nonadrenergic noncholinergic (NANC) neurons. [6] [7] The transmitters for cholinergic and adrenergic neurons are acetylcholine and norepinephrine, respectively. NANC neurons are a general term for several kinds of neurons of which the transmitters are neither acetylcholine nor norepinephrine. 6) Serotonin, vasoactive intestinal peptide (VIP), substance P, somatostatin and so on are well known as a transmitter for NANC neurons. 8) Nitric oxide (NO) is also recognized as another transmitter for NANC neuron 9) and it has been found that NO is implicated as a modulator of blood ‰ow, motility, electrolyte and water transport and so on. 10) The eŠect of ENS on the small-intestinal functions has been intensively studied in respect to the regulation of the smooth muscle [1] [2] [3] [11] [12] [13] and the transport of water and W or electrolytes. [4] [5] 12, [14] [15] [16] [17] However, the information about the eŠect of ENS on the membrane permeability of the gastrointestinal tract is very limited 12, 16, 18) and the regulation of drug absorption by ENS has never been systematically evaluated.
To understand systematically how ENS regulates the drug absorption from the small intestine, we,ˆrst of all, tried to estimate the eŠect of ENS on the absorption of a poorly absorbable drug in the present study. Phenol red was employed as a poorly absorbable model compound and its absorbability was estimated by the vascular and luminal perfusion technique, [19] [20] [21] [22] which can make us evaluate the substantial absorption to the vascular circulation under several conditions of ENS by adding a given neurotransmitter into the vascular perfusate. Furthermore, the membrane permeability and transmucosal electrical resistance (TER) were evaluated by using a Ussing-type chamber [23] [24] to understand the eŠect of ENS on the passive transport of drug from the small intestine.
Materials and Methods
Materials: Antipyrine, dextran-70 (Mw 70000) and L-glutamine were purchased from Tokyo Chemical Industry Co. (Tokyo, Japan). Phenol red, (-)-epinephrine, bethanechol, 4-methylaminoantipyrine, an internal standard for antipyrine, and FITCdextran (Mw 40000) were obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). Bovine serum albumin (BSA) was purchased from Iwai Chemicals Company Ltd. (Tokyo).
Animals: Male Wistar rats (Japan SLC, Hamamatsu, Japan), maintained at 259 C and 55z humidity, were allowed free access to standard laboratory chow (Clea Japan, Tokyo) and water. They were fasted for 24 hr prior to and during the experiment, but were allowed free access to water. Rats weighing 250¿300 g were randomly assigned to each experiment group. Our investigations were performed after approval by our local ethical committee at Okayama University and in accordance with``Principles of Laboratory Animal Care (NIH publication #85-23)''.
Vascular-luminal perfusion study: A vascularly perfused jejunal segment was prepared basically according to the method by Windmueller et al. 19) with the minor modiˆcation. Figure 1 schematically illustrates the vascular-luminal perfused rat intestine preparation. Brie‰y, after rats were anesthetized with intraperitoneal injection of pentobarbital (30 mg W kg), the 10-cm segment of jejunum from 5 cm below the ligament of Treitz was identiˆed and the contents in this segment were washed out by slowly introducing ice-cold saline. A silicone tubing (i.d. 3.0 mm, o.d. 5.0 mm) was placed in both ends of the segment and one of the tubes at proximal side is connected with a peristaltic pump (Atto corporation, Tokyo) for luminal perfusion. On the other hand, after intravenous administration of heparin (200 U), the polyethylene cannulae (i.d. 0.5 mm, o.d. 0.8 mm), which is connected with a peristaltic pump for the vascular perfusion, was inserted to the superior mesenteric artery. The single-pass perfusion of perfusate, Krebs-Ringer bicarbonate buŠer (pH 7.4) including 5.5 mM D-glucose, 3z BSA, 2.5z dextran-70 and 0.8 mM L-glutamine, was begun immediately at 0.8 mL W min. Epinephrine (10 mM), an adrenergic agonist, or bethanechol (1 mM), a cholinergic agonist, was dissolved in the vascular perfusate and delivered to the perfused intestinal segment. The mesenteric arteries and veins for other intestinal segments were ligated and then the left jugular vein and carotid artery were severed. Finally, the out‰ow cannulae (i.d. 1.1 mm, o.d. 1.6 mm) was introduced into the portal vein. After about 10-min vascular perfusion, the single-pass perfusion of drug solution into the lumen was begun at 0.6 mL W min. Phenol red, a poorly absorbable model compound (1 mM), or antipyrine, a well absorbable model compound (0.5 mM), was dissolved in saline including FITC-dextran (5 mg W mL) as an unabsorbable marker. Basically, the vascular perfusion protocol was as follows: theˆrst term, the vascular perfusate without any agonist is infused for 20 min (basal); the second term, the vascular perfusate containing epinephrine or bethanechol is infused for 20 min (drug infusion); the third term, the vascular perfusate without any agonist is infused for 20 min again (recovery).
In-vitro transport study and TER measurement: The contents in the small intestine were washed out by slowly introducing ice-cold saline. The 10-cm segment of the jejunum was isolated and opened, and then the muscularis propria was immediately stripped oŠ. The resulting jejunal sheet was mounted in a diŠusion chamber with 1.25 cm 2 of exposed area (Corning Costar Japan). Both sides of the tissue were bathed with 6 mL of Ringer's solution containing 1.2 mM NaH2PO4, 125 mM NaCl, 5 mM KCl, 1.4 mM CaCl 2 , 10 mM NaHCO 3 and 2 mg W mL D-glucose, which was aerated with 95z O2 and 5z CO2 and maintained at 379 C. The tissue was short-circuited to zero transmucosal electrical potential diŠerence (PD) by a short-circuit current ampliˆer (CEZ-9000, Nihon Kohden Co., Tokyo). PD and shortcircuit current were measured at 10-min intervals. TER was calculated following Ohm's law. After preincubation for 25 min to stabilize the electrical condition of the tissue, the solution in the donor side and one in the receptor side were exchanged for a drug solution and a Ringer's solution containing an adrenergic or cholinergic agonist, respectively, and then the transport experiments started. The solutions in both sides are circulated by gas lift with 95z O2 and 5z CO2 throughout the transport studies. Samples of 1 mL were drawn out of the receptor side at 10-min intervals to 90 min. An equal volume of Ringer's solution containing an agonist was immediately added to the receptor side after each sampling. Analytical method: Phenol red was determined by a spectrophotometer (Shimadzu UV-260, Shimadzu, Kyoto, Japan) at 560 nm after alkalinization with 1N NaOH. Antipyrine was determined by HPLC, which consists of a model LC-6A HPLC pump (Shimadzu), a model SIL-9A system controller (Shimadzu), and a model SPD-6A UV detector (Shimadzu) set at 254 nm. A ChemcoPak NUCLEOSIL column (150×4.6 mm i.d.; pore size, 120 Å; particle size, 5 mm; MACHEREY-NAGEL Inc., Easton, PA, USA) was used at room temperature. The mobile phase consists of 20 mM phosphate buŠer (pH 7.4)-methanol, 65:35 (v W v), delivered at 1.0 mL W min. The coe‹cient of variation (CV) for standard curves ranged from 1.0 to 8.7z and the squared correlation coe‹cient was over 0.999. FITC-dextran was determined ‰uorospec-trophometrically at 485 nm for excitation and at 515 nm for emission (Shimadzu DR3 ‰uorescent spectrophotometer).
Data analysis: In the vascular-luminal perfusion study, the net water ‰ux was calculated by the following equation:
Net water ‰ux＝Qin-Qout＝Qin･ Ø 1-Cin C out » (1) where Qin and Qout mean the luminal in‰ow rate and out‰ow rate, respectively. C in and C out represent FITCdextran concentration in the in‰ow perfusate and in the out‰ow perfusate, respectively. Absorption clearance, CLabs, was calculated based on the equation (2):
where Q vessel out and Q vessel out mean the out‰ow rate of vascular perfusate and the drug concentration in the vascular out‰ow perfusate, respectively. Furthermore, to estimate the change in CLabs quantitatively, the appearance in the vascular perfusate, the acceleration, was determined as follows:
In the membrane transport study, the cumulative amount transported to receptor side was calculated according to the following equation (4):
where Qtn and Ctn indicate cumulative amount trans- ported to the receptor side and the concentration in the receptor side at time t n , respectively. The volume of receptor solution and the sampling volume are 6.0 mL and 1.0 mL in the equation (4), respectively. Apparent permeability (Papp) was calculated by the equation (5):
where dQ W dt, A and C0 reveal the permeation rate, the exposing surface area and the initial concentration of phenol red, respectively. Statistical analysis: Results are expressed as the mean±SE of at least three experiments. Analysis of variance (ANOVA) was used to test the statistical signiˆcance of diŠerences between groups. Statistical signiˆcance in the diŠerences of the means was determined by Student's t-test or Dunnet's method.
Results and Discussion
It is well know that ENS regulates the motility [1] [2] [3] [11] [12] [13] and function [4] [5] 12, [14] [15] [16] [17] of gastrointestinal tract. However, the eŠect of ENS on drug absorption from the small intestine has never been systematically investigated. In the present study, we tried to estimate how ENS regulates the intestinal absorption of a poorly absorbable drug. First of all, the validation was performed for the vascular-luminal perfused rat intestine preparation. Figure 2 shows the recovery of vascular perfusate, net water ‰ux and absorption clearance (CL abs ) of antipyrine, a well absorbable drug. The out‰ow of vascular perfusate was averaged at 3.98± 0.02 mL W 5 min, corresponding to 99.5z of recovery. The water transfer wasˆxed at the absorptive direction around 10 min after starting the vascular perfusion, and reached the steady state before 20 min and kept it until 60 min. Net water ‰ux was calculated as 4.98±0.18 mL W min. The absorption of antipyrine was steady throughout 60-min perfusion, showing 60.8±1.5 mL W min of CLabs. These results clearly indicate that the functional viability of the vascular-luminal perfused intestine is stably maintained. Figure 3 shows that epinephrine (Fig. 3(A) ) and bethanechol ( Fig. 3(B) ) added in the vascular perfusate certainly modulated one of the functions of the small intestine, the water transport. It is well known that water absorption is enhanced when the adrenergic neuron is activated. 25) On the other hand, the secretion of water into lumen is promoted under the condition where the cholinergic neuron is stimulated. [26] [27] [28] Figure 3 (A) or (B) clearly indicates that epinephrine or bethanechol in the vascular perfusate promoted the absorption or secretion of water in the vascular-luminal perfused intestine, respectively, conrming the validity of this intestine preparation for investigating the eŠect of ENS on drug absorption.
In the present study, we focused on the absorption of a poorly absorbable drug to estimate the change in the membrane permeability, because the absorption of a well absorbable drug might be in‰uenced by the change in the blood ‰ow rate. The perfusion was performed according to the protocol described in Materials and Methods section to estimate the changes clearly. Figure 4(A) shows the changes in CLabs of phenol red with or without epinephrine in the vascular perfusate. Although it was not expected that CL abs of phenol red kept increasing until 60 min, the infusion of epinephrine certainly prevented CLabs of phenol red from increasing. After switching the perfusate to one without epinephrine, CLabs started to increase again, but the Results are expressed as the mean value with a vertical bar showing S.E. of at least three experiments. □, control study; the vascular perfusate without any agonist was perfused throughout the perfusion study.
, the vascular perfusate without any agonist was infused for 20 min in thê rst (basal) and third (recovery) terms of perfusion. In the second term (drug infusion), the perfusate containing epinephrine (10 mM (A)) or bethanechol (1 mM (B)) was perfused for 20 min. Absorption clearance (CL abs ) of phenol red was calculated by following the equation (2) . Results are expressed as the mean value with a vertical bar showing S.E. of at least three experiments. Perfusion protocol was the same as that in Fig. 3 . Epinephrine or bethanechol was vascularly perfused at 10 mM or 1 mM, respectively. , control; , adrenergic or cholinergic agonist. * , pº0.05 compared with control.
values of CLabs were signiˆcantly lower than those of control study. The appearance of phenol red in the vascular perfusate was calculated as the unit of nL W min 2 ( Table 1) . During the infusion of epinephrine, the appearance was markedly lower than that for basal or recovery period. These results explicitly indicate that the stimulation of adrenergic neuron by epinephrine suppressed the intestinal absorption of phenol red. On the other hand, CL abs of phenol red kept increasing extensively by the infusion of bethanechol (Fig. 4(B) ) and the appearance was calculated as 129.4±23.6 nL W min 2 ( Table 1) , which is much larger than that for basal period. Furthermore, removing bethanechol from the vascular perfusate caused the abrupt decrease in CLabs, yielding to the negative value of the appearance. These results strongly indicate that the absorption of phenol red was signiˆcantly enhanced following the activation of cholinergic neuron by bethanechol.
In the vascular-luminal perfused intestine, the steady state for the absorption of phenol red was not observed throughout the experiments. Usually, epinephrine or norepinephrine is used for maintaining the intestinal function, especially avoiding hyper-secretion, hypermotility and low vascular resistance, in the vascular perfused intestine preparations. 19, 22, 29) As the eŠect of epinephrine itself is what we would like to know in the present study, we intended not to include epinephrine in the basic composition of the vascular perfusate. However, as the viability of the perfused intestine was maintained well in terms of the recovery of the vascular perfusate, net water ‰ux and CLabs of antipyrine, it was unexpected that CL abs of phenol red kept increasing during the perfusion in the control study. The diŠerence in the change of absorbability between antipyrine and phenol red suggests that the constant stimulation of adrenergic neuron would be needed to maintain the tightness of the small intestine that substantially aŠects the absorbability of poorly absorbable drugs such as phenol red, but does not aŠect that of well absorbable drugs such as antipyrine. Therefore, this observation also indicates that the stimulation of adrenergic neuron by epinephrine functions to suppress the drug absorption from the small intestine. Furthermore, results in Fig. 4 clearly show the reversible eŠect of epinephrine and bethanechol on CLabs, so we can conclude that the activation of adrenergic neuron or of cholinergic neuron decrease or increase the small-intestinal absorption of a poorly absorbable drug, respectively.
To investigate the change in the membrane permeability of the small intestine, the in-vitro transport study was performed using the small-intestinal sheet from which the mascularis propria was removed (Fig. 5) . Figure 5 (A) and (B) show the transport of phenol red and TER, respectively, when epinephrine or bethanechol was added into the serosal side of the intestinal sheet. In the case of adrenergic stimulation by epinephrine, the transport of phenol red was signiˆcantly suppressed (Papp＝2.77±0.61×10
-5 cm W min, pº0.01), compared with the control (Papp＝6.09±0.24 ×10 -5 cm W min), which supports the observation that the absorption of phenol red was signiˆcantly decreased in the vascular-luminal perfusion study. Figure 5(B) shows that TER was substantially increased by epinephrine. These results, therefore, suggest that the membrane permeability attenuated by epinephrine could be at least partly attributed to the paracellular pathway tightened by the stimulation of adrenergic neuron. On the other hand, although the eŠect of bethanechol added into the serosal side was not statistically signiˆcant, the increasing tendency of permeability ( Fig. 5(A) , Papp＝7.51±0.78×10
-5 cm W min) and decreasing tendency of TER (Fig. 5(B) ) was observed. This change in the permeability and TER might not be large enough to explain the distinctive and reversible increase in the absorption of phenol red (Fig. 4(B) ). Hayden and Carey also reported that the eŠect of carbachol added into the serosal side of the isolated piglet jejunum was not signiˆcant. 16) The reason for this quantitative discrepancy remains to be clariˆed, but the lack of myenteric neurons in the isolated intestinal sheet might be a possible reason. In the vascular-luminal perfused intestine, the signal from the myenteric neuron stimulated by bethanechol and W or the interplay between myenteric and submucosal neurons through the interconnectingˆbers between the two plexuses could in‰uence the function of perfused intestine preparation, 5) whereas there is no contribution of myenteric neurons in the isolated intestinal sheet.
The change in the absorbability observed in the present study also clearly indicated that the solvent drag eŠect 30) is excluded from the possible mechanisms for the increase or decrease in the absorption of phenol red. That is to say, under the condition where cholinergic neuron was stimulated by bethanechol, the secretory ‰ux was predominant for water ( Fig. 3(B) ). However, the absorption of phenol red was signiˆcantly increased as shown in Fig. 4(B) and Table 1 . Furthermore, CL abs of phenol red was signiˆcantly decreased (Fig. 4(A) and Table 1 ) under the condition where the water absorption was remarkably enhanced by epinephrine (Fig. 3(A) ). These results explicitly indicate that the change in the direction of drug transport is opposite to that in the direction of the net water ‰ux. However, as it is quite possible that the secretion of phenol red is enhanced via the solvent drag, the membrane permeability might be enhanced more than estimated by the net absorption of phenol red. Neunlist et al., have very recently reported the possible regulation of the intestinal permeability by ENS and the involvement of VIP in it, by employing the novel cell culture system. 18) Although a lot of eŠort is needed to clarify the details about the regulation by ENS, it has also been suggested that ENS plays an important role to regulate the intestinal permeability.
In conclusion, the absorption of poorly absorbable drugs is regulated by ENS, and it is suppressed or enhanced by the stimulation of adrenergic or cholinergic neuron, respectively. The regulation by ENS would be at least in part due to the change in the tightness of the paracellular pathway.
